Martinez-Morales Patricia, Morán Cruz Irene, Roa-de la Cruz Lorena, Maycotte Paola, Reyes Salinas Juan Salvador, Vazquez Zamora Victor Javier, Gutierrez Quiroz Claudia Teresita, Montiel-Jarquin Alvaro Jose, Vallejo-Ruiz Verónica
CONACYT-Centro de Investigación Biomédica de Oriente, Mexican Institute of Social Security, Metepec, Puebla, México.
Centro de Investigación Biomédica de Oriente, Laboratory of Molecular Biology, Instituto Mexicano del Seguro Social, Metepec, Puebla, México.
PeerJ. 2021 Aug 31;9:e12081. doi: 10.7717/peerj.12081. eCollection 2021.
Dysregulation of glycogene expression in cancer can lead to aberrant glycan expression, which can promote tumorigenesis. Cervical cancer (CC) displays an increased expression of glycogenes involved in sialylation and sialylated glycans. Here, we show a comprehensive analysis of glycogene expression in CC to identify glycogene expression signatures and the possible glycosylation pathways altered.
First, we performed a microarray expression assay to compare glycogene expression changes between normal and cervical cancer tissues. Second, we used 401 glycogenes to analyze glycogene expression in adenocarcinoma and squamous carcinoma from RNA-seq data at the cBioPortal for Cancer Genomics.
The analysis of the microarray expression assay indicated that CC displayed an increase in glycogenes related to GPI-anchored biosynthesis and a decrease in genes associated with chondroitin and dermatan sulfate with respect to normal tissue. Also, the glycogene analysis of CC samples by the RNA-seq showed that the glycogenes involved in the chondroitin and dermatan sulfate pathway were downregulated. Interestingly the adenocarcinoma tumors displayed a unique glycogene expression signature compared to squamous cancer that shows heterogeneous glycogene expression divided into six types. Squamous carcinoma type 5 (SCC-5) showed increased expression of genes implicated in keratan and heparan sulfate synthesis, glycosaminoglycan degradation, ganglio, and globo glycosphingolipid synthesis was related to poorly differentiated tumors and poor survival. Squamous carcinoma type 6 (SCC-6) displayed an increased expression of genes involved in chondroitin/dermatan sulfate synthesis and lacto and neolacto glycosphingolipid synthesis and was associated with nonkeratinizing squamous cancer and good survival. In summary, our study showed that CC tumors are not a uniform entity, and their glycome signatures could be related to different clinicopathological characteristics.
癌症中糖原表达失调可导致聚糖表达异常,进而促进肿瘤发生。宫颈癌(CC)表现出参与唾液酸化和唾液酸化聚糖的糖原表达增加。在此,我们对CC中的糖原表达进行了全面分析,以确定糖原表达特征以及可能改变的糖基化途径。
首先,我们进行了微阵列表达分析,以比较正常组织和宫颈癌组织之间的糖原表达变化。其次,我们使用401个糖原基因,通过癌症基因组学cBioPortal的RNA测序数据来分析腺癌和鳞癌中的糖原表达。
微阵列表达分析表明,与正常组织相比,CC中与糖基磷脂酰肌醇(GPI)锚定生物合成相关的糖原增加,而与硫酸软骨素和硫酸皮肤素相关的基因减少。此外,通过RNA测序对CC样本进行的糖原基因分析表明,参与硫酸软骨素和硫酸皮肤素途径的糖原基因下调。有趣的是,与鳞状癌相比,腺癌肿瘤表现出独特的糖原表达特征,鳞状癌的糖原表达异质性分为六种类型。鳞状细胞癌5型(SCC - 5)显示参与硫酸角质素和硫酸乙酰肝素合成、糖胺聚糖降解、神经节和球鞘糖脂合成的基因表达增加,这与低分化肿瘤和不良预后相关。鳞状细胞癌6型(SCC - 6)显示参与硫酸软骨素/硫酸皮肤素合成以及乳糖和新乳糖鞘糖脂合成的基因表达增加,并且与非角化鳞状癌和良好预后相关。总之,我们的研究表明,CC肿瘤并非一个统一的实体,其糖组特征可能与不同的临床病理特征相关。